Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador

Rommel Guevara, Belén Prado-Vivar, Sully Márquez, Erika B. Muñoz, Mateo Carvajal, Juan José Guadalupe, Mónica Becerra-Wong, Stefanie Proaño, Rosa Bayas-Rea, Josefina Coloma, Michelle Grunauer, Gabriel Trueba, Patricio Rojas-Silva, Verónica Barragán, Paúl Cárdenas

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

SARS-CoV-2 reinfection is defined as a new infection with a different virus variant in an individual who has already recovered from a previous episode of COVID-19. The first case of reinfection in the world was described in August 2020, since then, reinfections have increased over time and their incidence has fluctuated with specific SARS-CoV-2 variant waves. Initially, reinfections were estimated to represent less than 1% of total COVID-19 infections. With the advent of the Omicron variant, reinfections became more frequent, representing up to 10% of cases (based on data from developed countries). The frequency of reinfections in Latin America has been scarcely reported. The current study shows that in Ecuador, the frequency of reinfections has increased 10-fold following the introduction of Omicron, after 22 months of surveillance in a single center of COVID-19 diagnostics. Suspected reinfections were identified retrospectively from a database of RT-qPCR-positive patients. Cases were confirmed by sequencing viral genomes from the first and second infections using the ONT MinION platform. Monthly surveillance showed that the main incidence peaks of reinfections were reached within four to five months, coinciding with the increase of COVID-19 cases in the country, suggesting that the emergence of reinfections is related to higher exposure to the virus during outbreaks. This study performed the longest monitoring of SARS-CoV-2 reinfections, showing an occurrence at regular intervals of 4-5 months and confirming a greater propensity of Omicron to cause reinfections.

Idioma originalInglés
Número de artículo951383
PublicaciónFrontiers in Cellular and Infection Microbiology
Volumen12
DOI
EstadoPublicada - 9 sep. 2022

Citar esto